Fed. Circ. Calls Foul On Cephalon's Provigil Patent
The Federal Circuit on Monday found Cephalon Inc.'s patent for narcolepsy medicine Provigil invalid and unenforceable, siding with Apotex Inc.'s argument that Cephalon officials purposely didn't tell regulators another company had...To view the full article, register now.
Already a subscriber? Click here to view full article